Image

GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV

GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV

Recruiting
18-89 years
All
Phase 2

Powered by AI

Overview

The goal of this clinical trial is to learn if the drug semaglutide works to reduce alcohol intake among adults living with HIV. The main questions it aims to answer are:

  1. Does semaglutide lower the average number of alcoholic beverages participants drink per week?
  2. Does semaglutide lower the average number of cigarettes participants smoke per day?
  3. Does semaglutide decrease the risk for cardiovascular disease among people living with HIV who drink alcohol and/or smoke tobacco?

Researchers will compare the effects of semaglutide to a placebo (a look-alike substance that contains no drug) to see if semaglutide works to lower the alcohol intake among participants each week.

Participants will:

  1. Take semaglutide for 3 months
  2. Visit the research clinic 3 times for checkups and tests
  3. Provide blood samples, stool samples, and saliva samples for tests.

Eligibility

Inclusion Criteria:

  • Ages 18-89
  • Prior diagnosis of HIV-1
  • Affiliated with Vanderbilt Comprehensive Care Clinic
  • On current ART regimen for at least 90 days prior to study entry with no missed doses for at least 7 consecutive days.
  • Most recent absolute CD4 count ≥ 300 cells/mm3 and drawn within 12 months of study enrollment
  • BMI ≥ 23 (calculated at screening)
  • Self-report of consuming alcohol in past 90 days
  • AUDIT-C ≥ 3 (male)/ ≥ 2 (female)
  • Has an established stable address at which they can receive mail and can be reached for the next 6 months
  • Willing and able to complete study procedures and follow-ups

Exclusion Criteria:

  • Known allergy to semaglutide
  • Currently taking GLP-1 RA (in the past 3 months)
  • History of diabetes defined by diagnosis in Problems List in medical record
  • History of pancreatitis
  • History of gastroparesis
  • Gallbladder disease (in the past 3 months)
  • History of medullary thyroid carcinoma
  • Family history of medullary thyroid carcinoma
  • History of multiple endocrine neoplasia syndrome type 2
  • Family history of multiple endocrine neoplasia syndrome type 2
  • Cognitive inability to consent
  • Barrier to speaking, hearing, reading, or writing English
  • Pregnant or breastfeeding, or planning to become pregnant in the next 6 months
  • Too ill to complete study procedures

Study details
    HIV
    Alcohol
    Smoking Cigarette
    Cardiovascular Disease Prevention

NCT07221214

Vanderbilt University Medical Center

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.